Christine de la Loge

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Anti Inflammatory

Respiratory Syncytial Virus

Myasthenia Gravis

Top Venues

Neurology and therapy

Patient related outcome measures

This page only lists publications with an associated author ORCID identifier.

Publications

Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Thomas H Brannagan
Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurology and therapy (2023)
Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Thomas H Brannagan
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurology and therapy (2023)
Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Thomas H Brannagan
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurology and therapy (2023)
Christine de la Loge, Fatoumata Fofana, Paul Williams, Sarah Rusch, Marita Stevens, Jane Scott
Monitoring Severity of Respiratory Syncytial Virus (RSV) in Infants and Young Children Using the Pediatric RSV Electronic Severity and Outcome Rating System (PRESORS): Results of Initial Quantitative Validation. Patient related outcome measures 12 (2021)